Showing results (431-440 of 478) with videos related to

Sort By:
Pageof 48
South Asian Journal of Cancer|December 31, 2025
Active Tuberculosis Risk Associated with Malignancies: A 4-Year Retrospective Study in a Tertiary Care HospitalPriyamvada Roy, Kiran Bala, Jaya Biswas, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 6, 2024
Autologous Stem Cell Transplantation in Adult Hodgkin Lymphoma at a Tertiary Care Center in India: Analysis of Outcomes and Prognostic FactorsSudhir Kumar, Atul Sharma, Sameer Bakhshi, et al.
International Journal of Applied & Basic Medical Research|October 22, 2020
Immunoglobulin Receptors Expression in Indian Colon Cancer Patients and Healthy Subjects Using a Noninvasive Approach and FlowcytometryRama Chaudhry, Vishwa Deepak Bamola, Projoyita Samanta, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 2, 2022
Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value SetGaurav Jyani, Atul Sharma, Shankar Prinja, et al.
BMJ Open|April 13, 2019
Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipientsJulie Ho, Atul Sharma, Kristine Kroeker, et al.
BMJ Supportive & Palliative Care|March 17, 2023
Dexamethasone-free antiemetic strategy for highly emetogenic chemotherapy: safety and efficacy-pilot studyVinod Sharma, Akash Kumar, Annie Baa, et al.
Clinical and Experimental Medicine|January 22, 2021
Lymphoma subtypes in India: a tertiary care center reviewSurabhi Jain, Moien Rasheed Lone, Ansh Goswami, et al.
Frontiers in Oncology|October 2, 2019
Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe AmplificationDeepshi Thakral, Gurvinder Kaur, Ritu Gupta, et al.
JCO Global Oncology|March 24, 2025
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From IndiaSneh Bhargave, Vinod Sharma, Babita Kataria, et al.
American Journal of Blood Research|March 20, 2023
Prognostic relevance of NPM1, CEBPA, and FLT3 mutations in cytogenetically normal adult AML patientsAparna Ningombam, Deepak Verma, Rajive Kumar, et al.
Pageof 48